NKB: Thoracolumbosacral Pedicle Screw System
What it covers
Intended to provide immobilization and stabilization of spinal segments in thoracic, lumbar, and sacral spine as an adjunct to fusion.
FDA’s definition of product code NKB, from the Product Classification database.
FDA flags NKB devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261217 | AnyPlus II Spinal Fixation System | GS Medical Co., Ltd. | Oct 2, 2026 | Special |
| K263062 | NOVIX Pedicle Screw System | Tdm Co., Ltd. | Oct 1, 2026 | Special |
| K263172 | SAS MIS Pelvic Incidence Rods | Spinal Alignment Solutions, Inc. | Sep 30, 2026 | Special |
| K262712 | Duet Spinal Fixation System | Duet Spine Holdings, LLC | Sep 30, 2026 | Traditional |
| K252139 | Kentrospine Viktr-MIS® Pedicle screw system | Rivarp Medical Pvt., Ltd. | Sep 27, 2026 | Traditional |
| K262067 | iFuse Granite Onyx Implant System | SI-BONE, Inc. | Sep 23, 2026 | Traditional |
| K262091 | FRAXION Spinal Fixation System | Ortler Global Tibbi Gerecler Anonim Sirketi | Sep 17, 2026 | Traditional |
| K262193 | RIVA® Posterior Fixation System with NanoACTIV Surface Technology; RIVA® Anchor Sacroiliac Fixation System with NanoACTIV Surface Technology | Xenix Medical | Sep 14, 2026 | Traditional |
| K262828 | KHEIRON® Spinal Fixation System, including patient specific K-ROD | S.M.A.I.O | Sep 4, 2026 | Special |
| K260362 | QUATTRO Spinal system (Open Configuration); QUATTRO-GADGET Spinal system (MIS Configuration) | MANTIZ Co., Ltd. | Jul 24, 2026 | Traditional |
Clearances by year
703 NKB 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 30 | 91 |
| 2025 | 24 | 61 |
| 2024 | 39 | 57 |
| 2023 | 44 | 72 |
| 2022 | 34 | 88 |
| 2021 | 32 | 61 |
| 2020 | 48 | 68 |
| 2019 | 39 | 84 |
| 2018 | 56 | 61 |
| 2017 | 63 | 69 |
| 2016 | 50 | 84 |
| 2015 | 55 | 90 |
| 2014 | 46 | 90 |
| 2013 | 35 | 73 |
| 2012 | 60 | 79 |
| 2011 | 48 | 84 |
Who submits
255 applicants cleared a NKB device since 2011. 72% of the clearances went to applicants in United States, then South Korea (7%), France (6%) and Switzerland (6%). By type: Traditional 67%, Special 32% and Abbreviated 1%.
| Applicant | Clearances since 2011 |
|---|---|
| Medtronic Sofamor Danek USA, Inc. | 40 |
| Alphatec Spine, Inc. | 19 |
| L&K BIOMED Co., Ltd. | 17 |
| K2m, Inc. | 16 |
| Life Spine, Inc. | 16 |
| Globus Medical, Inc. | 14 |
| SeaSpine Orthopedics Corporation | 14 |
| Medos International SARL | 13 |
How FDA classifies it
(1) Class II (special controls), when intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra; degenerative spondylolisthesis with objective evidence of neurologic impairment; fracture; dislocation; scoliosis; kyphosis; spinal tumor; and failed previous fusion (pseudarthrosis). These pedicle screw spinal systems must comply with the following special controls:
(i) Compliance with material standards;
(ii) Compliance with mechanical testing standards;
(iii) Compliance with biocompatibility standards; and
(iv) Labeling that contains these two statements in addition to other appropriate labeling information:
“Warning: The safety and effectiveness of pedicle screw spinal systems have been established only for spinal conditions with significant mechanical instability or deformity requiring fusion with instrumentation. These conditions are significant mechanical instability or deformity of the thoracic, lumbar, and sacral spine secondary to severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra, degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). The safety and effectiveness of these devices for any other conditions are unknown.”
“Precaution: The implantation of pedicle screw spinal systems should be performed only by experienced spinal surgeons with specific training in the use of this pedicle screw spinal system because this is a technically demanding procedure presenting a risk of serious injury to the patient.”
(2) Class II (special controls), when a rigid pedicle screw system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion in the treatment of degenerative disc disease and spondylolisthesis other than either severe spondylolisthesis (grades 3 and 4) at L5-S1 or degenerative spondylolisthesis with objective evidence of neurologic impairment. These pedicle screw systems must comply with the following special controls:
(i) The design characteristics of the device, including engineering schematics, must ensure that the geometry and material composition are consistent with the intended use.
(ii) Non-clinical performance testing must demonstrate the mechanical function and durability of the implant.
(iii) Device components must be demonstrated to be biocompatible.
(iv) Validation testing must demonstrate the cleanliness and sterility of, or the ability to clean and sterilize, the device components and device-specific instruments.
(v) Labeling must include the following:
(A) A clear description of the technological features of the device including identification of device materials and the principles of device operation;
(B) Intended use and indications for use, including levels of fixation;
(C) Identification of magnetic resonance (MR) compatibility status;
(D) Cleaning and sterilization instructions for devices and instruments that are provided non-sterile to the end user; and
(E) Detailed instructions of each surgical step, including device removal.
(3) Class II (special controls), when a semi-rigid system is intended to provide immobilization and stabilization of spinal segments in the thoracic, lumbar, and sacral spine as an adjunct to fusion for any indication. In addition to complying with the special controls in paragraphs (b)(2)(i) through (v) of this section, these pedicle screw systems must comply with the following special controls:
(i) Demonstration that clinical performance characteristics of the device support the intended use of the product, including assessment of fusion compared to a clinically acceptable fusion rate.
(ii) Semi-rigid systems marketed prior to the effective date of this reclassification must submit an amendment to their previously cleared premarket notification (510(k)) demonstrating compliance with the special controls in paragraphs (b)(2)(i) through (v) and paragraph (b)(3)(i) of this section.
From 21 CFR 888.3070. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 888.3070 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NKB clearances declared.
Ask about NKB
Questions about NKB
What is FDA product code NKB?
Product code NKB, “Thoracolumbosacral Pedicle Screw System” in FDA's classification database, is a Class II device type under 21 CFR 888.3070 (thoracolumbosacral pedicle screw system), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 914 clearances under NKB, 703 of them since 2011.
How many 510(k) clearances are there under NKB?
FDA’s 510(k) database listed 914 clearances under NKB as of Oct 29, 2026, 703 of them decided since 2011; the most recent decision was Oct 2, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a NKB 510(k)?
For the 61 NKB clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 77 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most NKB clearances?
Since 2011: Medtronic Sofamor Danek USA, Inc. (40), Alphatec Spine, Inc. (19), L&K BIOMED Co., Ltd. (17), K2m, Inc. (16) and Life Spine, Inc. (16). 255 applicants have cleared a NKB device in that time.